Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
|
|
5.
|
|
|
6.
|
|
|
7.
|
Clinical Phase I study with an Insulin-like Growth Factor-1 receptor inhibitor: experiences in patients with squamous non-small cell lung carcinoma. [electronic resource] by
- Ekman, Simon
- Frödin, Jan-Erik
- Harmenberg, Johan
- Bergman, Antonina
- Hedlund, Asa
- Dahg, Pia
- Alvfors, Carina
- Ståhl, Birgitta
- Bergström, Stefan
- Bergqvist, Michael
Producer: 20110701
In:
Acta oncologica (Stockholm, Sweden) vol. 50
Availability: No items available.
|
|
8.
|
Phase II randomized study of the IGF-1R pathway modulator AXL1717 compared to docetaxel in patients with previously treated, locally advanced or metastatic non-small cell lung cancer. [electronic resource] by
- Bergqvist, Michael
- Holgersson, Georg
- Bondarenko, Igor
- Grechanaya, Elena
- Maximovich, Alexey
- Andor, György
- Klockare, Maria
- Thureson, Marcus
- Jerling, Markus
- Harmenberg, Johan
Producer: 20170407
In:
Acta oncologica (Stockholm, Sweden) vol. 56
Availability: No items available.
|
|
9.
|
|
|
10.
|
Melflufen - a peptidase-potentiated alkylating agent in clinical trials. [electronic resource] by
- Wickström, Malin
- Nygren, Peter
- Larsson, Rolf
- Harmenberg, Johan
- Lindberg, Jakob
- Sjöberg, Per
- Jerling, Markus
- Lehmann, Fredrik
- Richardson, Paul
- Anderson, Kenneth
- Chauhan, Dharminder
- Gullbo, Joachim
Publication details: Oncotarget Sep 2017
In:
Oncotarget vol. 8
Availability: No items available.
|
|
11.
|
A phase I pilot study of the insulin-like growth factor 1 receptor pathway modulator AXL1717 in combination with gemcitabine HCl and carboplatin in previously untreated, locally advanced, or metastatic non-small cell lung cancer. [electronic resource] by
- Holgersson, Georg
- Bergström, Stefan
- Harmenberg, Johan
- Ringbom, Magnus
- Klockare, Maria
- Jerling, Markus
- Ekman, Simon
- Lundström, Kristina Lamberg
- Koyi, Hirsh
- Brandén, Eva
- Larsson, Olle
- Bergqvist, Michael
Producer: 20160322
In:
Medical oncology (Northwood, London, England) vol. 32
Availability: No items available.
|
|
12.
|
A novel oral insulin-like growth factor-1 receptor pathway modulator and its implications for patients with non-small cell lung carcinoma: A phase I clinical trial. [electronic resource] by
- Ekman, Simon
- Harmenberg, Johan
- Frödin, Jan-Erik
- Bergström, Stefan
- Wassberg, Cecilia
- Eksborg, Staffan
- Larsson, Olle
- Axelson, Magnus
- Jerling, Markus
- Abrahmsen, Lars
- Hedlund, Åsa
- Alvfors, Carina
- Ståhl, Birgitta
- Bergqvist, Michael
Producer: 20170110
In:
Acta oncologica (Stockholm, Sweden) vol. 55
Availability: No items available.
|
|
13.
|
First-in-human, phase I/IIa clinical study of the peptidase potentiated alkylator melflufen administered every three weeks to patients with advanced solid tumor malignancies. [electronic resource] by
- Berglund, Åke
- Ullén, Anders
- Lisyanskaya, Alla
- Orlov, Sergey
- Hagberg, Hans
- Tholander, Bengt
- Lewensohn, Rolf
- Nygren, Peter
- Spira, Jack
- Harmenberg, Johan
- Jerling, Markus
- Alvfors, Carina
- Ringbom, Magnus
- Nordström, Eva
- Söderlind, Karin
- Gullbo, Joachim
Producer: 20160912
In:
Investigational new drugs vol. 33
Availability: No items available.
|
|
14.
|
Melflufen plus dexamethasone in relapsed and refractory multiple myeloma (O-12-M1): a multicentre, international, open-label, phase 1-2 study. [electronic resource] by
- Richardson, Paul G
- Bringhen, Sara
- Voorhees, Peter
- Plesner, Torben
- Mellqvist, Ulf-Henrik
- Reeves, Brandi
- Paba-Prada, Claudia
- Zubair, Hanan
- Byrne, Catriona
- Chauhan, Dharminder
- Anderson, Kenneth
- Nordström, Eva
- Harmenberg, Johan
- Palumbo, Antonio
- Sonneveld, Pieter
Producer: 20200526
In:
The Lancet. Haematology vol. 7
Availability: No items available.
|
|
15.
|
ME-609: a treatment for recurrent herpes simplex virus infections. [electronic resource] by
- Harmenberg, Johan G
- Awan, Aftab R
- Alenius, Stefan
- Ståhle, Lars
- Erlandsson, Anna C
- Lekare, Gunilla
- Flink, Ola
- Augustsson, Elisabeth
- Larsson, Torbjörn
- Wikström, Ann-Charlotte
- Stierna, Pontus
- Field, Hugh J
- Larsson, Alf G
- Oberg, Bo
Producer: 20040604
In:
Antiviral chemistry & chemotherapy vol. 14
Availability: No items available.
|
|
16.
|
Bone-targeted radium-223 in symptomatic, hormone-refractory prostate cancer: a randomised, multicentre, placebo-controlled phase II study. [electronic resource] by
- Nilsson, Sten
- Franzén, Lars
- Parker, Christopher
- Tyrrell, Christopher
- Blom, René
- Tennvall, Jan
- Lennernäs, Bo
- Petersson, Ulf
- Johannessen, Dag C
- Sokal, Michael
- Pigott, Katharine
- Yachnin, Jeffrey
- Garkavij, Michael
- Strang, Peter
- Harmenberg, Johan
- Bolstad, Bjørg
- Bruland, Oyvind S
Producer: 20070828
In:
The Lancet. Oncology vol. 8
Availability: No items available.
|